New Findings Reported from Johns Hopkins University Describe Advances in Severe Acute Respiratory Syndrome (Neutralizing Activity and 3-month Durability of Tixagevimab and Cilgavimab Prophylaxis Against Omicron Sublineages In Transplant...).

Předmět:
Zdroj: Respiratory Therapeutics Week; 5/5/2023, p987-987, 1p
Abstrakt: According to news originating from Baltimore, Maryland, by NewsRx correspondents, research stated, "Neutralizing antibody (nAb) responses are attenuated in solid organ transplant recipients (SOTRs) despite severe acute respiratory syndrome-coronavirus-2 vaccination. Keywords: Baltimore; State:Maryland; United States; North and Central America; Antibodies; Blood Proteins; Coronaviridae; Coronavirus; Health and Medicine; Immunization; Immunoglobulins; Immunology; Nidovirales; Proteins; Public Health; RNA Viruses; Respiratory Tract Diseases and Conditions; Respiratory Tract Infections; Risk and Prevention; SARS; Severe Acute Respiratory Syndrome; Vaccination; Viral; Virology EN Baltimore State:Maryland United States North and Central America Antibodies Blood Proteins Coronaviridae Coronavirus Health and Medicine Immunization Immunoglobulins Immunology Nidovirales Proteins Public Health RNA Viruses Respiratory Tract Diseases and Conditions Respiratory Tract Infections Risk and Prevention SARS Severe Acute Respiratory Syndrome Vaccination Viral Virology 987 987 1 05/02/23 20230505 NES 230505 2023 MAY 1 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Current study results on Respiratory Tract Diseases and Conditions - Severe Acute Respiratory Syndrome have been published. [Extracted from the article]
Databáze: Complementary Index